Shift Bioscience
identified a novel single-gene target (SB000) for safer cellular rejuvenation, reversing cellular ageing as measured by DNA methylation clocks in multiple cell types without loss of cellular identity or signs of pluripotency;…
- Country
- United Kingdom
Safer single-gene target
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Partial epigenetic reprogramming | regenerative-personalized | High | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.